These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19140227)

  • 21. [Liver cirrhosis in diabetes mellitus; a complication not always recognized].
    Thewissen CM; Tiebosch AT; Kloppenburg WD; Haagsmna EB; Hoogenberg K
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2369-74. PubMed ID: 19055132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of hepatogenous diabetes in liver cirrhosis.
    Holstein A; Hinze S; Thiessen E; Plaschke A; Egberts EH
    J Gastroenterol Hepatol; 2002 Jun; 17(6):677-81. PubMed ID: 12100613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
    Bugianesi E; Vanni E; Marchesini G
    Curr Diab Rep; 2007 Jun; 7(3):175-80. PubMed ID: 17547834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
    Li X; Gao Y; Xu H; Hou J; Gao P
    Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis.
    Li X; Jiao Y; Xing Y; Gao P
    Biomed Res Int; 2019; 2019():5308308. PubMed ID: 31080822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.
    Yen YH; Kuo FY; Kee KM; Chang KC; Tsai MC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
    Dig Liver Dis; 2019 Jan; 51(1):142-148. PubMed ID: 30076015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndrome.
    Miyaaki H; Ichikawa T; Taura N; Miuma S; Shibata H; Isomoto H; Takeshima F; Nakao K
    Intern Med; 2011; 50(11):1137-41. PubMed ID: 21628926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes co-existing with chronic liver disease: clinical features and response to therapy.
    Chuhwak EK; Pam SD
    Niger J Med; 2007; 16(2):156-60. PubMed ID: 17694770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics].
    Anisonyan AV; Sandler YG; Khaimenova TY; Keyan VA; Saliev KG; Sbikina ES; Vinnitskaya EV
    Ter Arkh; 2020 Sep; 92(8):73-78. PubMed ID: 33346465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease: an emerging pathological spectrum.
    Zafrani ES
    Virchows Arch; 2004 Jan; 444(1):3-12. PubMed ID: 14685853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
    Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A
    Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus and cirrhosis of the liver: a prognostically unfavourable combination].
    Wlazlo N; Sauerwein HP; Schoon EJ; Stehouwer CD; Bravenboer B
    Ned Tijdschr Geneeskd; 2011; 155():A2213. PubMed ID: 21329534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
    Gao C; Fang L; Zhao HC; Li JT; Yao SK
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.
    Perseghin G; Mazzaferro V; Sereni LP; Regalia E; Benedini S; Bazzigaluppi E; Pulvirenti A; Leão AA; Calori G; Romito R; Baratti D; Luzi L
    Hepatology; 2000 Mar; 31(3):694-703. PubMed ID: 10706560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?
    Ramachandran TM; Rajneesh AHR; Zacharia GS; Adarsh RP
    J Clin Diagn Res; 2017 Sep; 11(9):OC01-OC05. PubMed ID: 29207749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.